Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2026-01-03 @ 10:36 PM
Study NCT ID:
NCT00271466
Status:
COMPLETED
Last Update Posted:
2011-05-18
First Post:
2005-12-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-02
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2002-04
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-30
First Submit QC Date:
None
Study First Post Date:
2006-01-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-05-17
Last Update Post Date:
2011-05-18
Last Update Post Date Type:
ESTIMATED